期刊文献+

心力衰竭患者血总胆红素与有创血液动力学及B型利钠肽相关研究 被引量:8

The association study of serum total bilirubin, plasma N-terminal proBNP and invasive hemodynamic parameters in patients with heart failure
原文传递
导出
摘要 目的评价心力衰竭(心衰)患者血胆红素与有创血液动力学监测指标、血浆N末端B型利钠肽原(NT-proBNP)和C反应蛋白(CLIP)的相关性。方法对130例心衰患者在入院12h内行漂浮导管监测和血总胆红素、血浆NT-proBNP和CRP等检测。结果肺毛细血管楔压[PCWP,(26.09比16.00)mmHg(1mmHg=0.133kPa)]、NT-proBNP[(3.36比2.91)pmol/L]和左室射血分数[(34.12比28.92)%]在高总胆红素血症组均较正常血总胆红素组显著增高(P值均〈0.05)。血总胆红素水平在高水平PCWP、右房压和NT-proBNP组较低水平组显著增高[(32.22比24.17)、(37.52比24.19)、(32.14比16.74)pmol/L,P值均〈0.05]。血总胆红素分别与NT-proBNP和右房压独立相关(β=0.39;β=0.29,P值均〈0.01)。结论心衰患者血总胆红素水平与右房压、PCWP和血浆NT-proBNP密切相关,是有助于心衰患者准确临床评价的重要生化指标。 Objective To explore the correlation among serum total bilirubin (TBil) , invasive hemodynamic parameters, plasma N-terminal proBNP (NT-proBNP) and C reactive protain (CRP)in patients with heart failure. Methods Invasive hemodynamic parameters derived from Swan-Ganz catheter, TBil, plasma NT-proBNP and CRP within 12 hours after hospital admission were analyzed in 130 patients with chronic heart failure [ New York Heart Association (NYHA) class Ⅱ -Ⅳ ]. Results Compared with those in non-hyperbilirubinemia group, pulmonary capillary wedge pressure (PCWP), NT-proBNP and left ventriculure ejection fraction were different significantly in total hyperbilirubinemia group [ (26. 09 vs 16.00) mm Hg(1 mm Hg=0. 133 kPa), (3.36 vs2.91) pmol/L, (34. 12 vs28.92)%, P〈0.05]. The serum TBil increased significantly in higher PCWP, right atrial pressure and NT-proBNP groups than those in lower level groups [(32.22 vs 24. 17), (37.52 vs 24. 19), (32. 14 vs 16.74) pmol/L, P 〈0.05]. Partial correlation analysis showed serum TBil was associated with PCWP, right atrial pressure, pulmonary vascular resistance index and NT-proBNP respectively ( r = 0. 21, P = 0. 02 ; r = 0. 33, P 〈 0. 01 ; r = 0. 20, P =0. 04;r = 0. 37, P 〈 0. 01, respectively). Multiple linear regression analysis showed both right atrial pressure and NT-proBNP correlated independently with serum TBil (β = 0. 39, P 〈 0. 01 ;β = 0. 29,P = 0. 01, respectively). Conclusion For patients with heart failure, serum TBil correlated well with right atrial pressure, PCWP and NT-proBNP; it is a reliable indicator for exact clinical evaluation of heart failure.
出处 《中华内科杂志》 CAS CSCD 北大核心 2010年第4期313-315,共3页 Chinese Journal of Internal Medicine
关键词 心力衰竭 胆红素 利钠肽 Heart failure Bilirubin Natriuretic peptide,brain
  • 相关文献

参考文献6

  • 1Shinagawa H, Inomata T, Koitabashi T, et al. Prognostic significance of increased serum bilimbin levels coincident with cardiac decompensation in chronic heart failure. Circ J,2008,72: 364-369. 被引量:1
  • 2Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail,2009,11 : 170-177. 被引量:1
  • 3刘震宇,张抒扬.脑钠肽测定在心力衰竭的诊断、预后评估和疗效监测中的应用[J].中华内科杂志,2008,47(5):425-427. 被引量:7
  • 4邵乐文,韩阳,王战坤,孙坚.床边即时脑钠肽检测对心力衰竭患者的诊断价值[J].中华内科杂志,2005,44(2):99-101. 被引量:40
  • 5Tang WH, Shrestha K, Van Lente F, et al. Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure. Am J Cardiol, 2008,101:370-373. 被引量:1
  • 6Nohria A, Tsang SW, Fang JC, et al. NoClinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol,2003,41:1797- 1804. 被引量:1

二级参考文献36

  • 1Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation, 2002,106:3068-3072. 被引量:1
  • 2Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med, 2004,350:647-654. 被引量:1
  • 3Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med, 2002, 347 : 1397-1402. 被引量:1
  • 4Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium : triumphs, concerns, and opportunities. N Engl J Med, 1997,337 : 1360-1369. 被引量:1
  • 5Cowie MR, Fox KF, Wood DA, et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J, 2002, 23:877-885. 被引量:1
  • 6Silver MA, Maisel A, Yancy CW, et al. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail,2004,10(5 Suppl 3) :1-30. 被引量:1
  • 7Maisel AS, McCuUough PA. Cardiac natriuretlc peptides: a proteomic window to cardiac function and clinical management. Rev Cardiovasc Med, 2003,4 Suppl 4:S3-S12. 被引量:1
  • 8McCullough PA, Sandberg KR. Sorting out the evidence on natriuretic peptides. Rev Cardiovase Med, 2003,4 Suppl 4 : S13- S19. 被引量:1
  • 9Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature, 1988,332:78-81. 被引量:1
  • 10Melanson SE, Lewandrowski EL. Laboratory testing for B-type natriuretic peptides (BNP and NT-proBNP) : clinical usefulness, utilization, and impact on hospital operations. Am J Clin Pathol, 2005,124 Suppl:S122-S128. 被引量:1

共引文献45

同被引文献80

引证文献8

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部